Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.

NCT07244380

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment

NCT07206264

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

Hebei Medical University Tumor Hospital Shijiazhuang, Hebei, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Shandong Cancer Hospital Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

NCT07198958

Conditions: Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +32 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT07107204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

NCT07131449

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

NCT07048353

Conditions: B Cell Lymphoma, CD30+ Peripheral T-cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of HUST Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

NCT07020260

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: University Medical Center Utrecht Utrecht, Netherlands

Princess Máxima Center for pediatric oncology Utrecht, Netherlands

View Trial Details

Not Yet Recruiting

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

NCT07008872

Conditions: CD7+ Acute Leukemia, CD7+ Lymphoma, Hemic and Lymphatic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma

NCT06788600

Conditions: Disease Attributes, Epstein-Barr Virus Associated Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Clinical Study on the Combination of Mitoxantrone Liposome Injection, Bendamustine, Etoposide, and Cytarabine for Pretreatment of Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma

NCT06757478

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions